About NeuScience

About company

NeuScience uses computer vision to detect phenotypic signals, resulting in a novel, pan-cancer biomarkers. The company's biological assay pairs the heterogeneity of patient tumor panels with the precision of single-cell phenotypic screening. NeuScience uses clinically-validated phenotypes and deep learning to discover novel single-cell biomarkers related to tumorigenesis, metastasis, toxicity, and drug resistance. The company was founded in 2018 by Guillermo Vela and Nicole Romano.